KIR2DL2 Antibody - C-terminal region
Applications | WB |
Reactivities | Human |
KIR2DL2 Antibody - C-terminal region
Applications | WB |
Reactivities | Human |
HLA-DQA1 Antibody - middle region
Applications | WB |
Reactivities | Human |
RFXAP Antibody - middle region
Applications | WB |
Reactivities | Human |
KLRC3 Antibody - N-terminal region
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal Anti-IFNA13 Antibody
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal Anti-IFNA4 Antibody
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal Anti-NFYB Antibody
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal Anti-IFNA16 Antibody
Applications | WB |
Reactivities | Human |
KIR2DS4 Antibody - N-terminal region
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal anti-NFYB antibody
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal Anti-HSPA6 Antibody
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal Anti-RFXAP Antibody
Applications | WB |
Reactivities | Human |
Rabbit Polyclonal Anti-LGMN Antibody
Applications | WB |
Reactivities | Human |
Rabbit polyclonal Anti-HLA-DQA2 Antibody
Applications | WB |
Reactivities | Human |
Rabbit polyclonal Anti-HLA-DQA2 Antibody
Applications | WB |
Reactivities | Human |